Cantor Fitzgerald Predicts Increased Earnings for CVS Health

CVS Health Corporation (NYSE:CVS) – Stock analysts at Cantor Fitzgerald raised their FY2025 earnings per share estimates for shares of CVS Health in a research note issued to investors on Thursday, October 30th. Cantor Fitzgerald analyst S. James now forecasts that the pharmacy operator will post earnings of $6.61 per share for the year, up from their prior forecast of $6.38. Cantor Fitzgerald has a “Overweight” rating and a $95.00 price target on the stock. The consensus estimate for CVS Health’s current full-year earnings is $5.89 per share. Cantor Fitzgerald also issued estimates for CVS Health’s FY2026 earnings at $7.11 EPS.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same period last year, the business posted $1.09 earnings per share. CVS Health’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS.

Several other analysts also recently weighed in on the company. Weiss Ratings restated a “hold (c)” rating on shares of CVS Health in a research note on Tuesday, October 14th. UBS Group boosted their price objective on shares of CVS Health from $79.00 to $96.00 and gave the stock a “buy” rating in a report on Friday, October 24th. Truist Financial restated a “buy” rating and issued a $95.00 price objective (up from $92.00) on shares of CVS Health in a report on Thursday. Sanford C. Bernstein boosted their price objective on shares of CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a report on Friday, September 5th. Finally, Evercore ISI boosted their price objective on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $86.33.

CVS Health Stock Performance

CVS Health stock opened at $78.13 on Friday. The company has a quick ratio of 0.62, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $99.09 billion, a P/E ratio of 205.61, a PEG ratio of 0.87 and a beta of 0.60. The stock’s 50 day moving average is $76.49 and its 200 day moving average is $69.04. CVS Health has a twelve month low of $43.56 and a twelve month high of $85.15.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.4%. CVS Health’s dividend payout ratio is currently 74.30%.

Insiders Place Their Bets

In related news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.22% of the company’s stock.

Institutional Trading of CVS Health

Hedge funds have recently bought and sold shares of the stock. Koshinski Asset Management Inc. raised its position in shares of CVS Health by 3.7% during the 1st quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator’s stock valued at $334,000 after buying an additional 178 shares in the last quarter. DAVENPORT & Co LLC raised its position in shares of CVS Health by 3.5% during the 1st quarter. DAVENPORT & Co LLC now owns 44,120 shares of the pharmacy operator’s stock valued at $2,987,000 after buying an additional 1,501 shares in the last quarter. Rossby Financial LCC purchased a new stake in shares of CVS Health during the 1st quarter valued at about $189,000. Aaron Wealth Advisors LLC raised its position in shares of CVS Health by 23.6% during the 1st quarter. Aaron Wealth Advisors LLC now owns 10,900 shares of the pharmacy operator’s stock valued at $738,000 after buying an additional 2,078 shares in the last quarter. Finally, First Horizon Advisors Inc. raised its position in shares of CVS Health by 36.4% during the 1st quarter. First Horizon Advisors Inc. now owns 9,415 shares of the pharmacy operator’s stock valued at $638,000 after buying an additional 2,513 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.